Omeprazole is more effective than cimetidine for the relief of all grades of gastro-oesoyhageal reflux disease-associated heartburn, irrespective of the presence or absence of endoscopic oesophagitis

Alimentary Pharmacology and Therapeutics

Volumn 11, Issue 4, 1997, Pages 755-763

  Bate, C M ^a   Green, J R B ^b   Axon, A T R ^c   Murray, F E ^d   Tildesley, G ^e   Emmas, C E ^f   Taylor, M D ^f  

^a ROYAL ALBERT EDWARD INFIRMARY   (United Kingdom)

^b CITY GENERAL HOSPITAL   (United Kingdom)

^c LEEDS GENERAL INFIRMARY   (United Kingdom)

^d NINEWELLS HOSPITAL   (United Kingdom)

^e University Hospital of Hartlepool   (United Kingdom)

^f Astra Pharmaceuticals Ltd   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CIMETIDINE; OMEPRAZOLE;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DYSPHAGIA; ENDOSCOPY; ESOPHAGITIS; ESOPHAGUS MUCOSA; FOOD REGURGITATION; GASTROESOPHAGEAL REFLUX; HEARTBURN; HUMAN; MAJOR CLINICAL STUDY; MULTICENTER STUDY; NAUSEA; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; REMISSION; VOMITING;

EID: 0030959728     PISSN: 02692813     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2036.1997.00198.x     Document Type: Article

References (13)

1. Green JRB. Is there such an entity as mild oesophagitis? Eur J din Res 1993; 4: 29-34.
2. Bate CM, Keeling PWN, O'Morain C, et al. Comparison of omeprazole and cimetidine in reflux oesophagitis: symptomatic, endoscopic, and histological evaluations. Gut 1990; 3: 968-72.
3. Bate CM, Crowe JP, Dickinson RJ, et al. Reflux oesophagitis resolves more rapidly with omeprazole 20 mg om than with ranitidine 150 mg bd: omeprazole 40 mg om provides further benefit in unresponsive patients. Br J Clin Res 1991; 2: 133-48.
4. Bate CM, Theodossi A, Tildesley G, et al. A comparison of omeprazole and ranitidine treatment strategies for reflux oesophagitis. Eur J Clin Res 1996; 8: 133-48.
5. DeMeester TR, Wang CI, Wernly JA, et al. Techniques, indications and clinical use of 24 hour oesophageal pH monitoring. J Thorac Cardiovasc Surg 1980; 79: 656-67.
6. Hungin AP, Bramble MG, O'Callaghan H. Reasons for variations in the use of open access gastroscopy by general practitioners. Gut 1995; 36: 180-2.
7. Johnson LF, DeMeester TR, Haggit RC. Endoscopic signs for gastro-oesophageal reflux objectively evaluated. Gastrointest Endosc 1976; 22: 151-5.
8. Bardhan KD, Morris P, Thompson M, et al. Omeprazole in the treatment of erosive oesophagitis refractory to high dose cimetidine and ranitidine. Gut 1990; 31: 745-9.
9. Havelund T, Laurensen S, Lauritsen K. Efficacy of omeprazole in lower grades of gastro-oesophageal reflux disease. Scand J Gastroenterol 1994; 29(Suppl. 201): 69-73.
10. Bate CM, Griffin SM, Keeling PW, et al. Reflux symptom relief with omeprazole in patients without unequivocal esophagitis. Aliment Pharmacol Ther 1996; 10: 547-55.
11. Jones DB, Howden CW, Burget DW, et al. Acid supression in duodenal ulcer: a meta-analysis to define optimal dosing with antisecretory drugs. Gut 1987; 28: 1120-7.
12. Galmiche J-P, Bruley Des Varannes S. Symptoms and disease severity in gastro-oesophageal reflux disease. Scand J Gastroenterol 1994; 29(Suppl. 201): 62-8.
13. Sontag S, Hirschowitz BI, Holt S, et al. Two doses of omeprazole versus placebo in symptomatic erosive esophagitis: the US multicentre study. Gastroenterology 1992; 102: 109-18.